Skip to main content
. 2015 Dec 2;6(40):42557–42568. doi: 10.18632/oncotarget.6449

Figure 3. Evaluation of the validated 9 miRNAs for the discrimination of active RA from non-active RA.

Figure 3

RA patients were divided into two groups: the active group (n = 44) and the non-active group (n = 31) based on DAS28. The bars denote the mean 2−Δcq values ± SD (*, P-values < 0.05 versus HCs; **, P-values < 0.01 versus HCs).